EE711 Cost-Effectiveness of Umeclidinium/Vilanterol (UMEC/VI) Versus Tiotropium/Olodaterol (TIO/OLO) in Patients With COPD: United Kingdom Payer Perspective
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.976
https://www.valueinhealthjournal.com/article/S1098-3015(23)04106-2/fulltext
Title :
EE711 Cost-Effectiveness of Umeclidinium/Vilanterol (UMEC/VI) Versus Tiotropium/Olodaterol (TIO/OLO) in Patients With COPD: United Kingdom Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04106-2&doi=10.1016/j.jval.2023.09.976
First page :
Section Title :
Open access? :
No
Section Order :
10470